NO995723L - Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer - Google Patents

Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer

Info

Publication number
NO995723L
NO995723L NO995723A NO995723A NO995723L NO 995723 L NO995723 L NO 995723L NO 995723 A NO995723 A NO 995723A NO 995723 A NO995723 A NO 995723A NO 995723 L NO995723 L NO 995723L
Authority
NO
Norway
Prior art keywords
treatment
autoimmune diseases
derivatives useful
triptolide derivatives
new
Prior art date
Application number
NO995723A
Other languages
English (en)
Norwegian (no)
Other versions
NO995723D0 (no
Inventor
Michel Jean Jung
Mahinda Wickramaratne
Michael Hepperle
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO995723D0 publication Critical patent/NO995723D0/no
Publication of NO995723L publication Critical patent/NO995723L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995723A 1997-05-23 1999-11-22 Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer NO995723L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86248897A 1997-05-23 1997-05-23
PCT/US1998/008470 WO1998052951A1 (en) 1997-05-23 1998-04-27 Novel triptolide derivatives useful in the treatment of autoimmune diseases

Publications (2)

Publication Number Publication Date
NO995723D0 NO995723D0 (no) 1999-11-22
NO995723L true NO995723L (no) 2000-01-21

Family

ID=25338616

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995723A NO995723L (no) 1997-05-23 1999-11-22 Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer

Country Status (20)

Country Link
EP (1) EP0983275B1 (de)
JP (1) JP2001525851A (de)
KR (1) KR20010012822A (de)
CN (1) CN1257507A (de)
AR (1) AR012723A1 (de)
AT (1) ATE222910T1 (de)
AU (1) AU741917B2 (de)
BR (1) BR9809678A (de)
CA (1) CA2287977A1 (de)
DE (1) DE69807466T2 (de)
DK (1) DK0983275T3 (de)
ES (1) ES2178207T3 (de)
HU (1) HUP0003398A3 (de)
IL (1) IL133088A0 (de)
NO (1) NO995723L (de)
NZ (1) NZ500762A (de)
PT (1) PT983275E (de)
TW (1) TW434235B (de)
WO (1) WO1998052951A1 (de)
ZA (1) ZA984174B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329148B1 (en) 1999-02-16 2001-12-11 The Board Of Trustees Of The Leland Stanford University Combined therapy of diterpenoid triepoxides and death domain receptor ligands for synergistic killing of tumor cells
EP1390358A4 (de) * 2001-03-15 2004-06-16 Pharmagenesis Inc Aminosäurederivate von triptolidverbindungen als immunmodulatoren und antikrebsmittel
EP2468277A1 (de) * 2002-05-31 2012-06-27 Pharmagenesis, Inc. Triptolidderivate zur Modulierung der Apoptose und Immunsuppression
CN100398544C (zh) * 2002-09-18 2008-07-02 成都达远药物有限公司 高免疫抑制活性的水溶性雷公藤内酯醇衍生物及其应用
WO2004058246A1 (en) * 2002-12-17 2004-07-15 Pharmagenesis, Inc. Triptolide derivatives as immunomodulator and anticancer agents
CN1223595C (zh) 2002-12-27 2005-10-19 中国科学院上海药物研究所 雷公藤内酯醇衍生物及其应用
US6943259B2 (en) * 2003-02-25 2005-09-13 Pharmagenesis, Inc. Halogenated triptolide derivatives as immunomodulators and anticancer agents
WO2005062913A2 (en) 2003-12-24 2005-07-14 Pharmagenesis, Inc. Triplide 5,6-derivatives as immunomodulators and anticancer agents
EP1722806A4 (de) 2004-02-09 2009-09-16 Pharmagenesis Inc Verfahren zur isolierung von triptolid-verbindungen aus tripterygium wilfordii
WO2005084365A2 (en) 2004-03-02 2005-09-15 Pharmagenesis, Inc. Triptolide lactone ring derivatives as immunomodulators and anticancer agents
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
WO2006044496A2 (en) 2004-10-13 2006-04-27 Pharmagenesis, Inc. Identification and screening of triptolide target molecules
CN104387406A (zh) * 2009-02-05 2015-03-04 药物起源公司 作为抗癌药和免疫调制剂的雷公藤内酯 c-环衍生物
EP3248981B1 (de) * 2015-10-29 2022-03-09 Hangzhou Weben Pharmaceuticals Inc. C14-hydroxylveresterte aminosäurederivate von triptolid sowie herstellungsverfahren und verwendung davon
CN114716503B (zh) * 2022-03-23 2024-03-12 广东省中医院(广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院) 一种雷公藤氯内酯醇的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4005108A (en) * 1973-04-03 1977-01-25 Research Corporation Novel anti-leukemic diterpenoid triepoxides
US5430054A (en) * 1989-12-22 1995-07-04 Jiangsu Family Planning Institute Preparation methods of diterpene lactone compounds and application of the same to antifertility
US5663335A (en) * 1996-03-01 1997-09-02 Pharmagenesis, Inc. Immunosuppressive compounds and methods

Also Published As

Publication number Publication date
AR012723A1 (es) 2000-11-08
AU741917B2 (en) 2001-12-13
HUP0003398A3 (en) 2001-09-28
PT983275E (pt) 2003-01-31
DK0983275T3 (da) 2002-12-23
ES2178207T3 (es) 2002-12-16
JP2001525851A (ja) 2001-12-11
HUP0003398A2 (en) 2001-03-28
ZA984174B (en) 1998-11-23
ATE222910T1 (de) 2002-09-15
CA2287977A1 (en) 1998-11-26
DE69807466D1 (de) 2002-10-02
KR20010012822A (ko) 2001-02-26
DE69807466T2 (de) 2003-04-24
BR9809678A (pt) 2000-07-11
EP0983275B1 (de) 2002-08-28
HK1026096A1 (en) 2000-12-01
TW434235B (en) 2001-05-16
AU7260798A (en) 1998-12-11
NO995723D0 (no) 1999-11-22
EP0983275A1 (de) 2000-03-08
NZ500762A (en) 2001-08-31
WO1998052951A1 (en) 1998-11-26
IL133088A0 (en) 2001-03-19
CN1257507A (zh) 2000-06-21

Similar Documents

Publication Publication Date Title
FI973292A7 (fi) Substituoituja isoksatsoleja tulehduksen hoitamiseksi
NO991955D0 (no) FremgangsmÕte for behandling av hydrokarboner
NO995113D0 (no) Substituerte benzopyranderivater for behandling av inflammasjon
NO983284D0 (no) Antikoagolante midler egnet i behandling av trombose
NO994256D0 (no) SmÕ molekyler som er anvendelige ved behandling av inflamasjonssykdom
NO995095L (no) Substituerte imidazoler nyttig ved behandlingen av inflammasjonssykdommer
FI962141A0 (fi) Rytmihäiriöitä vastustavat bentsodiatsepiinit
FI962249A7 (fi) Substituoituja pyratsolyylibentseenisulfonamideja tulehduksen hoitoa varten
NO995221D0 (no) Sulfonamider for behandling av endotelinmedierte sykdommer
NO995723D0 (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO973178D0 (no) Indol-derivater anvendelige ved behandling av osteporose
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
NO995722D0 (no) Nye triptolidderivater som er anvendbare ved behandling av autoimmune sykdommer
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
FI971527L (fi) Indolijohdannaisten käyttö erilaisten sairauksien hoitoon
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20001894L (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
TR199800068A3 (tr) Benzofenon türevlerinin hazirlanmasina yönelik metodlar.
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
NO306402B1 (no) 3-arylalkenyl-1,2,4-oksadiazolderivater og deres anvendelse, samt mellomprodukter for oppnaaelse av derivatene
NO986053L (no) Anticonvulsivt virkende derivater for anvendelse ved behandling av psoriasis
NO930436L (no) Fremgangsmåte ved fremstilling av baderom
NO985325D0 (no) Anvendelse av substituert azaspiran ved behandling av astma

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application